These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28704276)

  • 1. Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine.
    Harvey EL; Burroughs RL; Baker LE
    Behav Pharmacol; 2017 Oct; 28(7):586-589. PubMed ID: 28704276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
    Harvey EL; Baker LE
    Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.
    Risca HI; Baker LE
    Psychopharmacology (Berl); 2019 Mar; 236(3):963-971. PubMed ID: 30554256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats.
    Thomas AM; Cargile KJ; Lunn JA; Baker LE
    Behav Pharmacol; 2021 Sep; 32(6):524-532. PubMed ID: 34397448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.
    Seaman RW; Doyle MR; Sulima A; Rice KC; Collins GT
    Behav Pharmacol; 2021 Aug; 32(5):357-367. PubMed ID: 33587482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats.
    Berquist MD; Baker LE
    Behav Pharmacol; 2017 Aug; 28(5):394-400. PubMed ID: 28598863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.
    Saber I; Milewski A; Reitz AB; Rawls SM; Walker EA
    Psychopharmacology (Berl); 2019 Mar; 236(3):1015-1029. PubMed ID: 30980094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
    Wakeford AGP; Sherwood AM; Prisinzano TE; Bergman J; Kohut SJ; Paronis CA
    Int J Neuropsychopharmacol; 2021 Aug; 24(8):656-665. PubMed ID: 33909067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
    Risca HI; Zuarth-Gonzalez JD; Baker LE
    Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats.
    Powell KR; Koppelman LF; Holtzman SG
    Behav Pharmacol; 1999 Dec; 10(8):707-16. PubMed ID: 10780285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone.
    Berquist MD; Thompson NA; Baker LE
    Psychopharmacology (Berl); 2017 Nov; 234(21):3271-3278. PubMed ID: 28815279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenedioxypyrovalerone (MDPV) impairs working memory and alters patterns of dopamine signaling in mesocorticolimbic substrates.
    Bernstein DL; Nayak SU; Oliver CF; Rawls SM; Rom S
    Neurosci Res; 2020 Jun; 155():56-62. PubMed ID: 31302200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.
    Nguyen JD; Aarde SM; Cole M; Vandewater SA; Grant Y; Taffe MA
    Neuropsychopharmacology; 2016 Oct; 41(11):2759-71. PubMed ID: 27277119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.
    Philogene-Khalid HL; Hicks C; Reitz AB; Liu-Chen LY; Rawls SM
    Drug Alcohol Depend; 2017 Sep; 178():119-125. PubMed ID: 28646714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
    Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
    Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats.
    Hicks C; Huang P; Ramos L; Nayak SU; Caro Y; Reitz AB; Smith GR; Lee DY; Rawls SM; Liu-Chen LY
    ACS Chem Neurosci; 2018 Jun; 9(6):1327-1337. PubMed ID: 29597343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.